Nutrition
Drumstick flowers, often overlooked in many diets, are emerging as a nutritional powerhouse with a range of health benefits, as…
Health
The U.S. Food and Drug Administration (FDA) has approved the first generic version of Victoza (liraglutide injection), a glucagon-like peptide-1 (GLP-1) receptor agonist. This medication, available as an 18 milligram/3 milliliter injection, is indicated for improving glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes.
Articles
Easy access to the internet, changing lifestyles, and improving technology have made online gaming popular across the globe. The online…